ARMO BioSciences, Inc. Stock: price and insider trades · United States
ARMO BioSciences, Inc.: what insiders have been doing
We have very little insider data for ARMO BioSciences, Inc. so far: the most recent filing dates from 22 June 2018. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended March 2018 · cache
- 3,709,356 shares@ US$50.0090.1% of flowCommon StockSEC:0000899243-18-017726:0
- 409,547 shares@ US$50.009.9% of flowCommon StockSEC:0000899243-18-017726:1
- 4,266,683 shares@ US$50.00100.0% of flowCommon StockSEC:0000899243-18-017718:0
- 404,900 shares@ US$50.00100.0% of flowCommon StockSEC:0000899243-18-017785:0
- 809,865 shares@ US$50.00100.0% of flowCommon StockSEC:0000899243-18-017727:0
- 1,214,700 shares@ US$50.00100.0% of flowCommon StockSEC:0000899243-18-017715:0
- 409,547 shares@ US$50.009.9% of flowCommon StockSEC:0000899243-18-017711:1
- 3,709,356 shares@ US$50.0090.1% of flowCommon StockSEC:0000899243-18-017711:0
- ●
Same trade as the filing by Kleiner Perkins Caufield & Byers XIV, LLC, counted once
213M USD19SEC4,266,683 shares@ US$50.00100.0% of flowCommon StockSEC:0000899243-18-017712:0 - 809,800 sharesCommon StockSEC:0000899243-18-002486:0
- 607,350 sharesCommon StockSEC:0000899243-18-002282:0
- 404,900 sharesCommon StockSEC:0000899243-18-002283:0
- 4,266,683 sharesCommon StockSEC:0000899243-18-002284:0
- 3,709,356 sharesCommon StockSEC:0000899243-18-002285:0
- 409,547 sharesCommon StockSEC:0000899243-18-002285:1
- 1,214,700 sharesCommon StockSEC:0000899243-18-002279:0
- 4,266,683 sharesCommon StockSEC:0000899243-18-002278:0
- 607,350 sharesCommon StockSEC:0000899243-18-002277:0
- 3,709,356 sharesCommon StockSEC:0000899243-18-002286:0
- 409,547 sharesCommon StockSEC:0000899243-18-002286:1
- 1,059,148 sharesCommon StockSEC:0001209191-18-006068:0
- 2,580 sharesCommon StockSEC:0001209191-18-006068:1
- 728,080 sharesCommon StockSEC:0001209191-18-006068:2
- 1,772 sharesCommon StockSEC:0001209191-18-006068:3
- 200,786 sharesCommon StockSEC:0001209191-18-006068:4
25 of 30 declarations
About ARMO BioSciences, Inc.
ARMO BioSciences, Inc. is a biopharmaceutical company focused on developing immuno-oncology treatments. It aims to improve patient outcomes in cancer through innovative therapies.
